BIIB vs STEX · P/E 21, rev $9.89B vs rev $146.0K
Biogen Inc (BIIB) versus Streamex Corp (STEX) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Streamex Corp (STEX) is a capital markets company listed on NASDAQ.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported STEX revenue for 2026-06-30 was $146.0K. Net income was -$61.2M. STEX currently screens at market cap $216.5M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. STEX currently screens at market cap $216.5M.
Not investment advice. Open the BIIB and STEX stock pages for the full models.
Not investment advice.